NCT02873052 is a clinical trial of MyoVista in Coronary Artery Disease (CAD), sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center.

What drugs are being tested in NCT02873052?

Interventions in NCT02873052: MyoVista.

What condition does NCT02873052 study?

NCT02873052 studies Coronary Artery Disease (CAD), Atherosclerosis.

Is NCT02873052 still recruiting?

NCT02873052 is currently completed. Last updated 15 October 2024.

Last reviewed 2024-10-15 · How we verify

NCT02873052

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

MyoVista Measurements in Patients With Atherosclerosis and CAD

Completed Last updated 15 October 2024

What this trial tests

trial testing MyoVista in Coronary Artery Disease (CAD) in 200 participants. Completed in 22 February 2020.

Timeline

1 September 2015

Primary endpoint
22 September 2019

22 February 2020

Quick facts

Lead sponsor	Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Status	Completed
Study type	OBSERVATIONAL
Enrollment	200
Start date	1 September 2015
Primary completion	22 September 2019
Estimated completion	22 February 2020
Sites	1 location across United States

Drugs / interventions tested

MyoVista

Conditions studied

Coronary Artery Disease (CAD) — all drugs for Coronary Artery Disease (CAD) →
Atherosclerosis — all drugs for Atherosclerosis →

Sponsor

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Who can join

Adults 18 to 80, any sex, with Coronary Artery Disease (CAD) or Atherosclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The MyoVista system is a novel electrocardiogram technology that provides non-invasive assessment of myocardial abnormalities by analyzing energy changes at the cellular level of the myocardium.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Electrocardiogram-Based Machine Learning Emulator Model for Predicting Novel Echocardiography-Derived Phenogroups for Cardiac Risk-Stratification: A Prospective Multicenter Cohort Study.
Patel HB, Yanamala N, Patel B, Raina S, et al · · 2022 · cited 2× · PMID 35600228 · DOI 10.17294/2330-0698.1893

Verify or expand the search:

Other recruiting trials for Coronary Artery Disease (CAD)

Currently open trials in the same condition.

NCT07479433 — The NAVIGATE-PCI Registry: A New Approach to VIew CT-derived Guidance Ahead of Stenting To Plan Efficient PCI · recruiting
NCT07349875 — Colchicine Treatment for Non-Flow-Limiting Coronary Plaque by Coronary CTA: A Randomized Controlled Trial · Phase 4 · recruiting
NCT07277686 — AI Facial Analysis Algorithm to Screening Coronary Artery Disease in High-Risk Community Population · recruiting
NCT07148518 — Comparison of Upper and Lower Limb Maximal Exercise Capacities and Arterial Stiffness in Patients With CAD · recruiting
NCT07392021 — Effects of a Recovery-Promoting Program in Patients Undergoing CABG Surgery · NA · active not recruiting

Other Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center trials

Trials by the same sponsor.

NCT04526860 — Determine if Human Infant Weight Gain Can be Modulated to Prevent Obesity · NA · withdrawn
NCT02720874 — Multidisciplinary Approach for Treat To Target In Rheumatoid Arthritis · NA · withdrawn
NCT04918719 — Intravenous N-Acetylcysteine for the Treatment of Acute Ischemic Stroke · Phase 2 · completed
NCT06342609 — Effect of Colchicine on Progression of Known Coronary Atherosclerosis in Patients With Stable Coronary Artery Disease · Phase 4 · completed
NCT05398692 — Long COVID-19 Rehabilitation & Recovery Research Program · NA · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02873052 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Last refreshed: 15 October 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02873052.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing